Hochschulschrift
Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
35 Bl.
- Sprache
-
Englisch
- Anmerkungen
-
Dresden, Techn. Univ., Diss., 2007
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 12:15 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
![Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development
![Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development](/assets/placeholder/searchResultMediaUnknown.png)
Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development
Control of cytomegalovirus by myeloid dendritic cells
Chemogenetic silencing of differentiating cortical neurons impairs dendritic and axonal growth
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Dietary and blood determinants of antioxidant capacity of human blood plasma
Studies on dendritic cells and "leukemia derived dendritic cells" in the treatment of acute myeloid leukemia and myelodysplastic syndrome
Identification of human peripheral blood monocyte derived pro-inflammatory dendritic cells
Effect of mycophenolic acid on phenotypic, migratory and allostimulatory properties of myeloid dendritic cells
Native human blood dendritic cells as potent effectors in tumor directed cytotoxicity
Characterization of human dendritic cell subsets by whole blood flow cytometry analysis
Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development
Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development
Control of cytomegalovirus by myeloid dendritic cells
Chemogenetic silencing of differentiating cortical neurons impairs dendritic and axonal growth
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Dietary and blood determinants of antioxidant capacity of human blood plasma
Studies on dendritic cells and "leukemia derived dendritic cells" in the treatment of acute myeloid leukemia and myelodysplastic syndrome
Identification of human peripheral blood monocyte derived pro-inflammatory dendritic cells
Effect of mycophenolic acid on phenotypic, migratory and allostimulatory properties of myeloid dendritic cells
Native human blood dendritic cells as potent effectors in tumor directed cytotoxicity
Characterization of human dendritic cell subsets by whole blood flow cytometry analysis
Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development
Myeloid derived suppressor cell activation by combined lipopolysaccharide plus interferon-γ [interferon-gamma] treatment impairs dendritic cell development
Control of cytomegalovirus by myeloid dendritic cells
Chemogenetic silencing of differentiating cortical neurons impairs dendritic and axonal growth
Acute myeloid leukemia (AML) immunotherapy with genetically programmed dendritic cells
Transcriptomics of myeloid dendritic cells during mycobacterial infection and vaccination
Dietary and blood determinants of antioxidant capacity of human blood plasma
Studies on dendritic cells and "leukemia derived dendritic cells" in the treatment of acute myeloid leukemia and myelodysplastic syndrome
Identification of human peripheral blood monocyte derived pro-inflammatory dendritic cells
Effect of mycophenolic acid on phenotypic, migratory and allostimulatory properties of myeloid dendritic cells
Native human blood dendritic cells as potent effectors in tumor directed cytotoxicity